PROM1 and glioblastoma: Therefore, tumor growth effect of MSCs tropism toward GBM remains controversial: (i) CD133+ GBM cells maintain only a subset of primary GBM; probably, CD133− cells also participate in the process of modulating the tropism and (ii) the intrinsic factor such as dose of MSCs and timing of implantation should be tested in future trials.